healthOct 9, 202313:32pending

Comparison of Antiplatelet Monotherapies after Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks

Get every episode summarized

Each time JACC This Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

About this episode

Commentary by Dr. Valentin Fuster

Get every episode summarized

Each time JACC This Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

American College of CardiologyHost

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

More episodes

Comparison of Antiplatelet Monotherapies after Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks

Get every episode summarized

About this episode

Get every episode summarized

Hosts & guests

More from JACC This Week

March 10, 2026: Inside JACC Stats: The State of CV Health in Focus | JACC this W...

March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inh...

February 24, 2026: ACHD Guideline in Focus—From Survival to Stewardship | JACC T...

February 17, 2026: Women's Cardiovascular Health in Focus: From Inclusion to Red...